About the job

About the RoleWe are looking for an experienced CMC Technical Writer to join a growing biopharmaceutical organisation developing biologics and biosimilar products.The role will focus on preparing, coordinating and reviewing high-quality CMC regulatory documentation, with particular emphasis on CTD Module 3. You will work closely with CMC, Manufacturing, Quality, Analytical Development, Regulatory Affairs and Process Development teams to translate complex technical information into clear, accurate and submission-ready documentation.

• Key ResponsibilitiesAuthor and coordinate CTD Module 3 (CMC) documentation for biologic and/or biosimilar products.
• Prepare and update CMC sections covering drug substance, drug product, manufacturing processes, analytical methods, specifications, validation and stability.
• Translate complex CMC and scientific data into clear, regulatory-compliant documentation.
• Work closely with CMC, QA, QC, Manufacturing, Process Development and Regulatory Affairs stakeholders.
• Support preparation of regulatory submissions, amendments and responses to Health Authority questions.
• Review and edit technical documentation for accuracy, consistency and regulatory compliance.
• Manage input from multiple technical contributors and ensure documentation is delivered to agreed timelines.
• Support lifecycle management and updates to existing CMC documentation.

• RequirementsProven experience as a CMC Technical Writer / CMC Writer / Regulatory CMC Writer within the pharmaceutical or biotechnology industry.
• Strong hands-on experience authoring CTD Module 3.
• Experience with biologics, biosimilars or other complex biological products.
• Good understanding of pharmaceutical development and CMC principles across Drug Substance and Drug Product.
• Experience working cross-functionally with CMC, Quality, Manufacturing, Analytical and Regulatory teams.
• Strong scientific writing, editing and document management skills.
• Ability to understand complex technical information and communicate it clearly within regulatory documentation.
•